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It was shown previously [{1984) EMBO J. 3, 45334591 that after treatment of the human erythroleukemia 
cell line HEL with phorbol ester and dimethyl sulfoxide there was a marked increase in the amounts of 
megakaryotic markers, especially of platelet cc-granule proteins and platelet glycoproteins. In order to inves- 
tigate this differentiation process further we have studied the expression of the mRNA encoding PDGF-A 
and PDGF-B (c-sis). Upon addition of the phorbol ester to the culture medium the expression of the c-sis 
transcript was enhanced about 7-fold over a period of 4 days. With dimethyl sulfoxide there was no signifi- 
cant stimulation of the expression. Addition of cycloheximide to HEL cells treated for a short period with 
phorbol ester superinduced the expression of the c-sis gene. The HEL cells did not express the A-chain 
mRNA even in the presence of phorbol ester or dimethyl sulfoxide. This leads us to propose that synthesis 
of the PDGF-A chain and PDGF-B chain is differentially regulated in the megakaryocytic-like HEL cell 
line. 
Megaka~~ytic differentiation; Platelet~e~ved growth factor; Phorbol ester; (HEL cell) 
1. INTRODUCTION 
The polypeptide platelet-derived growth factor 
(PDGF) is a potent mitogen for cultured cells of 
mesenchymal origin (review [l I). The main source 
of PDGF in human serum is platelets, which are 
released from megakaryocytes. PDGF is thought 
to be synthesized in megakaryoc~es and then 
packaged into the a-granules of platelets [2]. Thus 
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platelets appear to be a storage vehicle for PDGF 
and other mitogens that are released when platelets 
are exposed to foreign surfaces during blood clot- 
ting or when they adhere to sites of blood vessel 
injury. 
PDGF-like proteins are also secreted by cells in 
culture: the monocytes as circulating cells, en- 
dothelial cells and smooth muscle cells as resident 
cells and in several transformed cell lines like 
blastoma and sarcoma cell lines and erythroleu- 
kemia cells [1,3]. 
Sequence analysis of human PDGF from 
plateiets after reduction of the disulfide bonds 
revealed two distinct but related sequences [4], sug- 
gesting that PDGF from human platelets is either 
a homodimer of two equal chains or a heterodimer 
of two different chains. These chains were subse- 
quently termed A and B [5]. PDGF from porcine 
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platelets appears to consist of B-B homodimers [6] 
while PDGF secreted by an osteosarcoma cell line 
is an A-A homodimer [7]. 
The B-chain of PDGF is highly homologous 
(greater than 9O(ro) to the predicted amino acid se- 
quence of p28’-s’s, the putative transforming pro- 
tein of simian sarcoma virus (SSV). This led to the 
suggestion that transformation by SSV might be 
mediated by production of a PDGF-like molecule 
through an autocrine stimulation mechanism [4,8]. 
The human hemopoietic cell line HEL was 
established from a patient with Hodgkin’s disease 
who later developed erythroleukemia. This cell line 
is capable of spontaneous and hemin-induced 
globin synthesis [9]. HEL cells can be induced to 
differentiate and express megakaryotic markers by 
treatment with dimethyl sulfoxide or phorbol ester 
[lo]. After DMSO induction 4% of HEL cells 
show the megakaryocytic phenotype by the ap- 
pearance of granules with the morphology of 
platelet o-granules. Before induction with the 
phorbol ester TPA only 0.01% of the cells were 
positive for the platelet-specific proteins von 
Willebrand factor and platelet factor-4. After TPA 
induction 1% of the cells were positive for this 
marker and exhibited a marked increase in the 
characteristic platelet peroxidase activity [lo]. 
HEL cells may therefore provide a suitable system 
to study differentiation to platelets and the expres- 
sion and biosynthesis of platelet-specific proteins, 
investigations which are otherwise hampered by 
the low abundance of megakaryocytes in the bone 
marrow [ll]. 
We have used Northern blot analysis to in- 
vestigate the expression of the PDGF B- and 
PDGF A-chains in HEL cells during differentia- 
tion and could show that with the tumor- 
promoting agent phorbol 1Zmyristate 13-acetate 
(PMA) only the synthesis of the PDGF-B mRNA 
can be induced. Although the PDGF A-chain is 
constitutively expressed in different transformed 
cells and in human placenta, the mRNA for this 
growth factor cannot be detected in HEL cells us- 
ing the Northern blot technique. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
The HEL cell line was a gift from Dr P. Martin 
(Seattle, USA). PMA, cycloheximide and A23187 
90 
were purchased from Sigma (St. Louis, USA). 
Cells were grown in RPM1 1640 medium contain- 
ing 10% fetal calf serum supplemented with 2 mM 
glutamine, 1 mM pyruvate and antibiotics (100 U 
penicillin, 1OOpg streptomycin and 50,ug gen- 
tamycin per ml) in a humidified atmosphere with 
5% CO2. The human osteosarcoma cell line U-20s 
was kindly provided by Dr B. Westermark (Upp- 
sala, Sweden). The human bladder carcinoma cell 
line T 24 was from the American Type Culture 
Collection (ATCC HTB4; Rockville, USA). The 
human fibrosarcoma cell line HA1781 was kindly 
provided by Dr S. Aaronson. Cell lines were grown 
in DMEM medium containing 10% FCS and an- 
tibiotics (100 U penicillin, 100 pg streptomycin 
and 5Opg gentamycin per ml) in a humidified at- 
mosphere with 10% COZ. Cells were harvested 1, 
2 or 4 days after the addition of inducers. Cells 
treated with DMSO had a low proliferation rate, 
whereas PMA rendered the cells adherent and 
stopped proliferation. 
2.2. RNA isolation and Northern analysis 
Cytoplasmic RNA was isolated from cell 
populations using the guanidinium/cesium chlo- 
ride method [12]. Polyadenylated RNA was 
selected by chromatography over oligo(dT)-cellu- 
lose columns (Pharmacia, Sweden). RNA was elec- 
trophoresed through 1.2% formamide-agarose 
gels or 1.2% formaldehyde-agarose gels and blot- 
ted onto 0.45 pm nitrocellulose filters (Schleicher 
& Schiill, Dassel, FRG) using the methods in [ 131. 
A 2.0 kbp BamHI restriction fragment from the 
c-sis clone pMVW-2 [14] was subcloned into SP6 
Gemini plasmids (Promega Biotechn, Madsin, 
USA) in E. coli HBlOl. Clones with inserts in 
reverse orientation were selected by restriction 
mapping. 32P-labeled RNA probes for hybridiza- 
tion to the PDGF B-chain were prepared using 
EcoRI-linearized plasmids and hybridization per- 
formed as in [ 151. To obtain a probe for the PDGF 
A-chain a sized cDNA library from U-20s cells 
[14] was screened by standard techniques [16] us- 
ing a synthetic 22-mer oligomer complementary to 
the amino-terminus of the PDGF A-chain gene 
[17]. Two independent clones were isolated, one 
with a 1.3 kbp insert (pPGF-1) and the other with 
a 2.75 kbp insert (pPGF-2). Plasmid DNA isolated 
from the identified clones was digested with 
restriction enzymes to characterize the inserts. The 
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PDGF A-chain probe was the “P-labeled, nick- 
translated pPGF-1 BumHI fragment. Hybridiza- 
tion was done as described [ 131. After hybridiza- 
tion, autoradiography was done at - 70°C for l-7 
days using Kodak XAR-5 films and intensifying 
screens. The intensities of the bands obtained in 
different blotting experiments were quantified us- 
ing a laser densitometer (LKB, Sweden), in order 
to estimate the level of mRNA expression. The 
sizes of the RNAs were estimated by comparison 
with the RNAs of tobacco mosaic virus (6395 b) 
and brome mosaic virus (3234, 2865, 2114, 876 b) 
separated in the same gel and stained with 
ethidium bromide. 
3. RESULTS 
3.1. Induction of the c-sis gene in HEL cells 
The basal level of c-sis mRNA expression in un- 
treated HEL ceils was very low. PMA treatment of 
HEL cells resulted in increased levels of c-sis 
mRNA over a period of 4 days (fig.1). After 1 day 
there was a slight increase (Zfold, not shown), and 
Fig.1. Induction of c-sis mRNA by PMA and DMSO. 
HEL cell cultures were treated with PMA (160 nM), 
DMSO (1.25%) or PMA and A23187 (50 nM) for 2 and 
4 days, respectively, after which time the cytoplasmic 
RNA was isolated. RNA aliquots (20pg) were 
electrophoresed through a 1.2% formamide-agarose gel. 
An aliquot (2sg) of marker cytoplasmic RNA derived 
from T24 cells was also electrophoresed as an internal 
control of the hybridization experiment. Hybridization 
was performed using a c-sis fragment. Autoradiography 
was performed for 2 days. 
after 2 and 4 days PMA induced a 5- and 7-fold in- 
crease, respectively, in c-sis transcription. The 
kinetics of c-sis mRNA induction were comparable 
to those seen in K562 or HL-60 cells after PMA 
treatment [18,19]. 
To examine the effect of DMSO on expression 
of the PDGF-B chain, cells were treated for 2 and 
4 days, respectively, with DMSO before Northern 
blot analysis. As shown in fig. 1, DMSO had no ef- 
fect on c-sis mRNA expression in HEL cells. This 
result was unexpected, since the megakaryocytic 
phenotype of HEL cells is inducible with both 
PMA and DMSO. 
Synergistic effects have often been observed 
with phorbol esters and calcium ionophores, e.g. 
for mitogenesis of lymphocytes [20] and in human 
blood lymphocyte activation for the expression of 
the lymphokine interleukin 2 (IL-2) and interferon- 
gamma (IFN-y) [21,22]. Moreover, it has recently 
been shown that the human promyelocytic 
leukemia line HL-60 differentiated terminally into 
macrophage-like cells in the presence of sub- 
threshold concentrations of phorbol ester and the 
Ca*+ ionophore A23 187 [23]. 
We investigated whether the simultaneous treat- 
ment of HEL cells with PMA and A23187 had a 
significant effect on the expression of the c-sis 
mRNA. As shown in fig.2, the cotreatment of the 
cells did not alter the expression of the differentia- 
tion marker. 
To determine whether the responses to PMA is 
a primary induction process HEL cells were treated 
with PMA together with an inhibitor of protein 
synthesis, cycloheximide (CH), over a period of 
2 h. Addition of CH to PMA-induced cells led to 
a further increase in c-sis mRNA. After 4 days, ex- 
pression of the c-sis gene was increased up to 
1Zfold by this treatment, whereas the expression 
was increased only 7-fold in cells incubated with 
PMA alone. These results showed that induction 
by PMA over a short period in the presence of 
cycloheximide was independent of de novo protein 
synthesis. 
3.2. Expression of the PDGF-A mRNA in 
different cell types 
Because platelets released from megakaryocytes 
contain both A- and B-chain molecules we also in- 
vestigated the expression of the A-chain gene in 
differentiating HEL cells. 
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Fig.2. Induction of c-sis mRNA by PMA and 
cycloheximide. HEL cell cultures were treated with 
PMA or PMA and cycloheximide (20pg/ml), 
respectively, for 2 h and cytoplasmic RNA was isolated 
after 4 days. RNA aliquots (20 pg) were electrophoresed 
through a 1.2% formaldehyde-agarose gel. An aliquot 
(2.5 pg) of marker cytoplasmic RNA derived from T24 
cells was also electrophoresed with the RNA samples as 
an internal control of the hybridization experiment. 
Hybridization was performed using a c-sis fragment. 
Autoradiography was performed for 1 day. 
As shown in fig.3, uninduced HEL cells and 
cells after DMSO or PMA induction had no de- 
tectable level of PDGF-A mRNA, even when blots 
were exposed for a prolonged time. 
The expression of the A-chain gene was also in- 
vestigated in two transformed cell lines. The blad- 
der carcinoma cell line T24 is known to secrete 
PDGF-like activity into the medium. This cell line 
and also the fibrosarcoma cell line A1781 both ex- 
pressed c-sis mRNA (Weich, H.A., unpublished). 
Both cell lines expressed in approximately equal 
amounts three major transcripts of 2.8, 2.3 and 
1.7 kbp. This pattern has also been reported 
recently [17]. The exact relationship between the 
different mRNA species for PDGF-A is unknown 
but is believed to be the result of different splicing 
processes of the primary transcript. 
At this time, from primary cells only 
macrophages were examined for PDGF A-chain 
expression. They were negative for A- and B-chain 
Fig.3. Expression of the PDGF A-chain mRNA in 
different cell lines. Cytoplasmic RNA was isolated from 
the transformed cell lines T24 (human bladder 
carcinoma), HA1781 (human fibrosarcoma), and from 
human placenta. RNA from HEL cells was isolated after 
4 days after the addition of PMA (160 nM), DMSO 
(1.25%). 10 pg RNA were electrophoresed through 
1.2% formaldehyde-agarose gels. Hybridization was 
performed using a PDGF A-chain cDNA fragment. 
Autoradiography was performed for 7 days. 
expression [ 171. Human placenta was found to be 
positive for B-chain expression [24]. We have used 
human placenta RNA to examine the expression of 
the PDGF A-chain. We found PDGF A-chain 
mRNA expression to be one-tenth of that detected 
with the two investigated transformed cell lines. 
4. DISCUSSION 
It was reported previously that PMA induction 
of HEL cells led to the synthesis of platelet pro- 
teins [lo]. Although markers for platelet glycopro- 
teins were detectable before induction, all the 
platelet markers increased following induction by 
DMSO and PMA, especially the a-granule pro- 
teins von Willebrand factor and platelet factor 4 
DOI. 
In untreated HEL cells the c-sis mRNA expres- 
sion is about l/l0 of that observed in T24 tumor 
cells (fig.2). Since T24 cells exhibit a similar level 
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of expression of c-sis mRNA to that in U-2 OS cells 
(Weich, H.A., unpublished), which were in turn 
shown to express about lo-20 copies per cell 
[25,26], our results indicate an expression rate of 
l-2 copies per untreated HEL cell. Accordingly, 
the observed 7-fold increase in c-sis mRNA expres- 
sion induced by PMA corresponds to 7-14 copies 
per cell. On the other hand only 1% of the PMA- 
induced HEL cells synthesized other a-granule 
proteins (von Willebrand factor and platelet factor 
4) [lo]. If this also holds for PDGF, a small 
percentage of the cells might express about 
700-1400 copies of the c-sis gene. 
We also showed that treatment with DMSO did 
not lead to an expression of the c-sis mRNA. These 
data suggest that the differentiation processes in- 
duced by DMSO or PMA respectively, are dif- 
ferent, at least in relation to the synthesis of 
platelet proteins. Similar findings were reported 
for c-sis gene expression in the human myeloid 
leukemia cell line HL-60 during monocytic dif- 
ferentiation. In the latter case c-sis mRNA was also 
detected in PMA-treated cells but not in DMSO- 
induced cells [19]. 
The effects of phorbol ester on cells are thought 
to be mediated by its ability to mimic the action of 
diacylglycerol in the activation of the protein 
kinase C, leading to a cellular response or a dif- 
ferentiation pathway [27]. Activation of protein 
kinase C by diacylglycerol or phorbol ester leads to 
stimulation of a signal pathway for short-term and 
long-term cellular responses. The expression of the 
proto-oncogenes c-fos and c-myc was rapidly 
stimulated in phorbol ester-treated cells [ 18,281. 
On the other hand, maximum induction of the c-sis 
mRNA within 4 days in HEL cells, cell lines HL-60 
and K 562 [18,19] suggests that the c-sis gene is 
regulated indirectly by-the biochemical events that 
may follow the activation of the protein kinase C 
or by independent pathways. 
The PDGF A- and B-chains are related in their 
amino acid sequence and both proteins are present 
in approximately equal quantities in human 
platelets. Although both proteins are biologically 
active and bind at the same cell surface receptor, 
they are coded for by different genes localized on 
different chromosomes [7,17]. 
The expression of the PDGF-A mRNA was in- 
vestigated in some human tumor cell lines. The ex- 
pression of this gene was found to be independent 
of expression of the PDGF-B gene and secretion of 
a PDGF-like growth factor activity correlated with 
expression of A- but not B-chain mRNA [ 171. The 
biological significance of the presence of both 
chains remains unknown. 
The presence of PDGF A-chain mRNA species 
was detected in the human tumor cell lines T24, 
HA1781 and human placenta using A-chain- 
specific cDNA probes (fig.3). Hybridization with 
the same probe under stringent hybridization con- 
ditions indicated the absence of PDGF-A mRNA 
species in HEL cells, not only in untreated cells but 
also after induction with DMSO or with the phor- 
bol ester PMA. 
Thus the present data suggest that expression of 
the PDGF-B gene and that of PDGF-A are con- 
trolled independently of each other in megakary- 
ocytic-like cells. 
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